IRIDEX Corporation (IRIX)
IRIX trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-01-03, https://www.sec.gov/Archives/edgar/data/1006045/000119312526140194/0001193125-26-140194-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-01-03.
Profile
| Field | Value |
|---|---|
| Ticker | IRIX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Country | United States |
| IPO year | 1996 |
| SEC CIK | 0001006045 |
| SEC industry code | Electromedical & Electrotherapeutic Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $52.7M |
| Net income | -$4.4M |
| Operating income | -$2.6M |
| Net margin | -8.4% |
| Operating margin | -4.9% |
| Revenue growth | +8.2% |
| Cash | $6.0M |
| Total assets | $29.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.2× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-08-18 |
| Cash and burn | $4.7M cash; operating cash flow -$433K a quarter. | Report 2026-07-04 |
| Shares outstanding | 17,564,912 (2026-08-13); 16,992,253 a year earlier; 16,229,103 three years earlier. | Cover page 2026-08-13 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-09-02 |
| Auditor | BPM LLP, San Jose, California, United States | PCAOB Form AP 2026-04-03 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $151K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-07-04 | $12.6M | -$1.3M | $174K | $4.7M | No debt tags | $51.6M | 10-Q 2026-08-18 |
| Q1 2026 2026-04-04 | $11.8M | -$524K | -$1.3M | $4.6M | No debt tags | $52.6M | 10-Q 2026-05-19 |
| Q4 2025 2026-01-03 | $14.7M | -$184K | $589K | $6.0M | $0 | $52.7M | 10-K 2026-04-02 |
| Q3 2025 2025-09-27 | $12.5M | -$1.6M | -$1.2M | $5.6M | $0 | $50.6M | 10-Q 2025-11-12 |
| Q2 2025 2025-06-28 | $13.6M | -$994K | -$397K | $6.8M | $0 | $49.7M | 10-Q 2026-08-18 |
| Q1 2025 2025-03-29 | $11.9M | -$1.7M | -$1.1M | $7.2M | $0 | $48.8M | 10-Q 2026-05-19 |
| Q4 2024 2024-12-28 | $12.7M | -$834K | -$1.2M | $2.4M | $2.7M | $48.7M | 10-K 2026-04-02 |
| Q3 2024 2024-09-28 | $11.6M | -$1.9M | -$3.1M | $3.9M | $2.7M | $48.4M | 10-Q 2025-11-12 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2024-09-25 |
| Latest annual report | 10-K | 2026-04-02 |
| Latest quarterly / interim | 10-Q | 2026-08-18 |
| Latest current report | 8-K | 2026-09-02 |
| Latest proxy DEFINITIVE ADDITIONAL MATERIALS | DEFA14A | 2026-04-24 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +4.5% |
| 1 month | -18.8% |
| 3 months | -15.9% |
| Year to date | -39.5% |
| 1 year | -22.5% |
| From 52-week high | -55.8% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ITOC | iTonic Holdings Ltd | $1.88 | -5.05% | $13.8M |
| NDRA | ENDRA Life Sciences Inc. | $4.42 | -1.78% | $6.6M |
| QTI | QT Imaging Holdings Inc. | $1.80 | -4.26% | $26.4M |
| ECOR | electroCore Inc. | $4.84 | -7.81% | $44.7M |
| POCI | Precision Optics Corporation Inc. | $4.97 | -4.97% | $54.6M |
| NUWE | Nuwellis Inc. | $4.48 | -8.57% | $2.4M |
| OM | Outset Medical Inc. | $3.39 | -9.12% | $64.0M |
| HYPR | Hyperfine Inc. | $0.6101 | -3.05% | $64.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier